81 related articles for article (PubMed ID: 24066112)
1. Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array.
Hu S; Qu Y; Xu X; Xu Q; Geng J; Xu J
PLoS One; 2013; 8(9):e74161. PubMed ID: 24066112
[TBL] [Abstract][Full Text] [Related]
2. Abnormal DNA-PKcs and Ku 70/80 expression may promote malignant pathological processes in gastric carcinoma.
Li W; Xie C; Yang Z; Chen J; Lu NH
World J Gastroenterol; 2013 Oct; 19(40):6894-901. PubMed ID: 24187467
[TBL] [Abstract][Full Text] [Related]
3. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.
Albarakati N; Abdel-Fatah TM; Doherty R; Russell R; Agarwal D; Moseley P; Perry C; Arora A; Alsubhi N; Seedhouse C; Rakha EA; Green A; Ball G; Chan S; Caldas C; Ellis IO; Madhusudan S
Mol Oncol; 2015 Jan; 9(1):204-17. PubMed ID: 25205036
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma.
Shintani S; Mihara M; Li C; Nakahara Y; Hino S; Nakashiro K; Hamakawa H
Cancer Sci; 2003 Oct; 94(10):894-900. PubMed ID: 14556663
[TBL] [Abstract][Full Text] [Related]
5. Differential role of repair proteins, BRCA1/NBS1 and Ku70/DNA-PKcs, in radiation-induced centrosome overduplication.
Shimada M; Kobayashi J; Hirayama R; Komatsu K
Cancer Sci; 2010 Dec; 101(12):2531-7. PubMed ID: 20825415
[TBL] [Abstract][Full Text] [Related]
6. ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers.
Abdel-Fatah TM; Arora A; Moseley P; Coveney C; Perry C; Johnson K; Kent C; Ball G; Chan S; Madhusudan S
BBA Clin; 2014 Dec; 2():10-7. PubMed ID: 26674120
[TBL] [Abstract][Full Text] [Related]
7. Loss of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in gastric cancers.
Lee HS; Yang HK; Kim WH; Choe G
Cancer Res Treat; 2005 Apr; 37(2):98-102. PubMed ID: 19956487
[TBL] [Abstract][Full Text] [Related]
8. Expression of immune checkpoint PD-1 in non-small cell lung cancer is associated with tumor cell DNA-dependent protein kinase.
Saar M; Narits J; Mägi L; Aaspõllu H; Vapper A; Kase M; Minajeva A; Vooder T; Tamm H; Buldakov M; Lavõgina D; Jaal J
Mol Clin Oncol; 2021 Oct; 15(4):211. PubMed ID: 34462666
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and Prognostic Significance of Inhibitor of Apoptosis Protein (IAP) Family Members in Lung Cancer: A Meta-Analysis.
Fung S; Knoefel WT; Krieg A
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439255
[TBL] [Abstract][Full Text] [Related]
10. Comparative Transcriptional Analysis of Pulmonary Arterial Hypertension Associated With Three Different Diseases.
Wang W; Jiang Z; Zhang D; Fu L; Wan R; Hong K
Front Cell Dev Biol; 2021; 9():672159. PubMed ID: 34336829
[TBL] [Abstract][Full Text] [Related]
11. miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5.
Meng X; Sun Y; Liu S; Mu Y
Oncol Lett; 2021 Apr; 21(4):282. PubMed ID: 33732358
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
13. Druggable binding sites in the multicomponent assemblies that characterise DNA double-strand-break repair through non-homologous end joining.
Kefala Stavridi A; Appleby R; Liang S; Blundell TL; Chaplin AK
Essays Biochem; 2020 Oct; 64(5):791-806. PubMed ID: 32579168
[TBL] [Abstract][Full Text] [Related]
14. Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma.
Zhang L; Wei Y; Yan X; Li N; Song H; Yang L; Wu Y; Xi YF; Weng HW; Li JH; Lin EH; Zou LQ
Ann Transl Med; 2019 Jul; 7(14):316. PubMed ID: 31475186
[TBL] [Abstract][Full Text] [Related]
15. [Advances in molecular mechanism of vascular remodeling in pulmonary arterial hypertension].
Xiao L; Tong X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 May; 48(1):102-110. PubMed ID: 31102364
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.
Sishc BJ; Davis AJ
Cancers (Basel); 2017 Jul; 9(7):. PubMed ID: 28684677
[TBL] [Abstract][Full Text] [Related]
18. DNA-PK Inhibition by NU7441 Enhances Chemosensitivity to Topoisomerase Inhibitor in Non-Small Cell Lung Carcinoma Cells by Blocking DNA Damage Repair.
Yanai M; Makino H; Ping B; Takeda K; Tanaka N; Sakamoto T; Yamaguchi K; Kodani M; Yamasaki A; Igishi T; Shimizu E
Yonago Acta Med; 2017 Mar; 60(1):9-15. PubMed ID: 28331416
[TBL] [Abstract][Full Text] [Related]
19. DNA Damage and Pulmonary Hypertension.
Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373
[TBL] [Abstract][Full Text] [Related]
20. The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC.
Wang C; Nie H; Li Y; Liu G; Wang X; Xing S; Zhang L; Chen X; Chen Y; Li Y
Sci Rep; 2016 Jun; 6():26526. PubMed ID: 27246533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
